Nexalin Technology NXL
NASDAQ NXL
$4.87 -0.18 (-3.56%)
At close: Sep 10, 2026 · 4:00 PM EDT

Nexalin Technology (NXL) Consolidated Net Income (2021 - 2026)

Nexalin Technology (NXL) posted Consolidated Net Income of -$2.2 million for Q2 2026, down 6.79% on a QoQ basis from -$2.1 million in Q1 2026, and down 41.63% year-over-year from -$3.8 million in Q2 2025.

Analysis

Nexalin Technology (NXL) Consolidated Net Income (2021 - 2026) Analysis & Trends

Nexalin Technology has reported Consolidated Net Income for 6 years, with the latest figure at -$2.2 million in Q2 2026.

  • On a quarterly basis, Consolidated Net Income fell 41.63% year-over-year to -$2.2 million in Q2 2026; TTM through Jun 2026 was -$9.0 million, a 1.57% decrease from a year earlier, with the FY2025 full-year figure at -$6.5 million, up 14.67% from the prior year.
  • Consolidated Net Income was -$2.2 million for Q2 2026 at Nexalin Technology, down from -$2.1 million in the prior quarter.
  • The five-year high for Consolidated Net Income was -$303646.0 in Q3 2022, with the low at -$2.8 million in Q4 2024.
  • Average Consolidated Net Income over 5 years is -$1.5 million, with a median of -$1.4 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: Consolidated Net Income surged 83.34% in 2022, then sank 656.54% in 2023.
  • Over 5 years, Consolidated Net Income stood at -$736919.0 in 2022, then fell by 5.94% to -$780669.0 in 2023, then plunged by 262.95% to -$2.8 million in 2024, then climbed by 16.12% to -$2.4 million in 2025, then advanced by 5.79% to -$2.2 million in 2026.
  • The last three Consolidated Net Income figures came in at -$2.2 million (Q2 2026), -$2.1 million (Q1 2026), and -$2.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 823.20 Mn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 1.48 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 905.00 Mn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 241.40 Mn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn -92.00 Mn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 249.10 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 201.00 Mn
10 Nexalin Technology 3.44 Mn 2.44 Mn 8,897.00 -2.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.24 Mn
Mar 31, 2026 -2.10 Mn
Dec 31, 2025 -2.38 Mn
Sep 30, 2025 -2.28 Mn
Jun 30, 2025 -1.58 Mn
Mar 31, 2025 -1.99 Mn
Dec 31, 2024 -2.83 Mn
Sep 30, 2024 -2.45 Mn
Jun 30, 2024 -1.28 Mn
Mar 31, 2024 -1.05 Mn
Dec 31, 2023 -780,669.00
Sep 30, 2023 -2.30 Mn
Jun 30, 2023 -822,437.00
Mar 31, 2023 -748,414.00
Dec 31, 2022 -736,919.00
Sep 30, 2022 -303,646.00
Jun 30, 2022 -445,103.00
Mar 31, 2022 -393,249.00
Dec 31, 2021 -595,928.00
Sep 30, 2021 -1.82 Mn